Zaloguj Zarejestruj się zadarmo

Lilly(Eli) & Co organizacji Net debt/EBITDA

Jaka jest wartość Net debt/EBITDA organizacji Lilly(Eli) & Co?

Wartość Net debt/EBITDA organizacji Lilly(Eli) & Co to 5.93

Jaka jest definicja Net debt/EBITDA?



The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.

The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.

Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization

Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.

Net debt/EBITDA firm w Health Care sektor na NYSE w porównaniu do Lilly(Eli) & Co

Czym się zajmuję organizacja Lilly(Eli) & Co?

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.

Firmy z net debt/ebitda podobne do Lilly(Eli) & Co